Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02054221
Other study ID # HOCM - 95
Secondary ID 1957
Status Completed
Phase N/A
First received December 27, 2013
Last updated July 1, 2015
Start date October 2013
Est. completion date May 2015

Study information

Verified date July 2015
Source Meshalkin Research Institute of Pathology of Circulation
Contact n/a
Is FDA regulated No
Health authority Russia: Ethics Committee
Study type Interventional

Clinical Trial Summary

Compare the results of reconstruction and mitral valve replacement in the surgical treatment of obstructive hypertrophic cardiomyopathy with severe mitral insufficiency.


Description:

Many years myoectomy for Morrow was the gold standard in the treatment of obstructive hypertrophic cardiomyopathy. Currently more retrospective data in the literature about the good results the extended septal myectomy. But the question remains what is best for patients with obstructive hypertrophic cardiomyopathy and severe mitral insufficiency: use extended myoectomy with mitral valve repair a or replacement.


Recruitment information / eligibility

Status Completed
Enrollment 82
Est. completion date May 2015
Est. primary completion date May 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Able to sign Informed Consent and Release of Medical Information forms

- Age = 18 years

- obstructive hypertrophic cardiomyopathy

- surgically significant mitral insufficiency

- II-IV (NYHA),

- average systolic pressure gradient greater than 50 mm Hg. Art. at rest;

- basal or medium ventricular obstruction

Exclusion Criteria:

- Related defect of the aortic valve;

- Organic mitral valve disease (dysplasia, rheumatic fever, infective endocarditis);

- Surgically significant coronary artery lesions;

- Patients requiring implantation of a cardioverter-defibrillator

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
myoectomy
The scheme of Extended septal myectomy: Two parallel incisions were made into the septal bulge and connected to remove the muscle mass. Myectomy was extended to the base of the papillary muscles, when midseptal thickening was present. The papillary muscles were grasped and pushed medially to visualize the abnormal connections between the papillary muscles and the anterior wall of the ventricle. A blade was used to divide the thickened abnormal attachments. A pituitary rongeur may be used to resect a portion of the junction of the papillary and lateral wall. This reduces the diameter of the papillary muscle and allows for posterior displacement of the anterior mitral leaflet. Division of abnormal attachments and thinning of the papillary muscles is critical for the treatment of SAM.
Mitral valve surgery
41 patients will be performed mitral valve replacement with complete excision of the subvalvular apparatus.
Mitral valve surgery
41 patients will be performed mitral valve repair. Results of mitral valve repair will be more appreciated intraoperatively. In case of unsatisfactory MV repair will reconnect the device artificial circulation and mitral valve replacement. There after, patients will be moved to the first group.

Locations

Country Name City State
Russian Federation Novosibirsk State Research Institute of Circulation Pathology Novosibirsk Novosibirsk territory

Sponsors (1)

Lead Sponsor Collaborator
Meshalkin Research Institute of Pathology of Circulation

Country where clinical trial is conducted

Russian Federation, 

References & Publications (1)

Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy With severe Mitral regurgitation

Outcome

Type Measure Description Time frame Safety issue
Primary The function of the mitral valve (mitral regurgitation return, prosthesis dysfunction) one year No
Secondary The pressure gradient in the output section of the left ventricle one year No
See also
  Status Clinical Trial Phase
Recruiting NCT05073094 - Esmolol for Myocardial Protection in Hypertrophic Obstructive Cardiomyopathy Phase 4
Completed NCT05850026 - Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy: Fix it in a Simple, Effective and Durable Way!
Completed NCT04777188 - Speckle Tracking Echocardiography Analysis of Left Ventricular Myocardium After Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy N/A
Withdrawn NCT04905173 - Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy N/A
Completed NCT04066777 - The Effect of TASH in Patients With HOCM N/A
Terminated NCT02674958 - Mobilization of Endothelial Progenitor Cells and Aspirin Phase 3
Not yet recruiting NCT04329689 - Hyp Obst Cardiomyopathy N/A
Not yet recruiting NCT05025644 - Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensional Transesophageal Echocardiography Under Provocative Dobutamine Stress Test Phase 4
Recruiting NCT05257772 - Electromechanically Optimised Right Ventricular Pacing In Hypertrophic Cardiomyopathy (EMORI-HCM) N/A
Recruiting NCT04470102 - Edge-to-edge Mitral Valve Repair in the Surgical Treatment for Hypertrophic Cardiomyopathy N/A
Recruiting NCT04355260 - The Clinical Research of the Safety and Effectiveness Evaluation for Using Echocardiography-guided Liwen RF Radiofrequency Ablation System to Treat Hypertrophic Obstructive Cardiomyopathy N/A
Active, not recruiting NCT06003478 - The Safety and Influencing Factors of Liwen Procedure in The Treatment of Hypertrophic Cardiomyopathy
Recruiting NCT05957419 - Transapical Beating-Heart Septal Myectomy in Patient With Hypertrophic Obstructive Cardiomyopathy: a Multi-Center Study N/A
Recruiting NCT02492399 - Comparisonof Extended Myoectomy and Myoectomy by Morrow in Patients With Hypertrophic Obstructive Cardiomyopathy (HOCM) N/A
Completed NCT04686487 - SterEotactic AbLative Radiotherapy in PatiEnts With HypertrophiC ObstrucTive Cardiomyopathy N/A
Completed NCT05671367 - Association Between Microvascular Resistance and Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy
Completed NCT05687487 - Residual or Recurrent Obstruction After Septal Myectomy
Enrolling by invitation NCT05100420 - Hypertrophic Cardiomyopathy Registry, Biobank and Imaging Data Repository
Not yet recruiting NCT04275544 - Risk Factors of Postoperative Complications in HCM Patients
Recruiting NCT06167876 - Safety and Efficacy of Stereotactic Body Radiotherapy in the Treatment of Hypertrophic Obstructive Cardiomyopathy N/A